Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03049592 · ClinicalTrials.gov registry record · NA

High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project Script

A NA study of Diabetes and Contraception, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03049592 is a NA study of Diabetes and Contraception that has completed, run by University of California, San Diego. The registered enrollment target is 30 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03049592, a NA study of Diabetes and Contraception, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

High-risk obstetrical patient Intervention to promote Birth Interval Spacing utilizing the Contraceptive CHOICE project script to reduce Unintended Subsequent pregnancies (HIBISCUS) is a collaborative study utilizing qualitative methods to assess the acceptability including a family planning specialist's postpartum contraception counseling during and after prenatal care among Latina obstetric women with pre-gestational diabetes. The investigators will compare the effectiveness of HIBISCUS versus usual contraceptive counseling on Long-Acting Reversible Contraception (LARC) use at 3 months postpartum.

Conditions Studied

Interventions

  • OTHER HIBISCUS counseling

Study Locations (1)

California

  • UC San Diego Health System - San Diego

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-07
Est. Completion 2017-10
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT03049592

The ClinicalTrials.gov registry entry for NCT03049592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which HIBISCUS counseling is the first listed.

NCT03049592 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03049592 about?

NCT03049592 is a clinical study titled "High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project Script". High-risk obstetrical patient Intervention to promote Birth Interval Spacing utilizing the Contraceptive CHOICE project script to reduce Unintended Subsequent pregnancies (HIBISCUS) is a collaborative study utilizing qualitative methods to assess the acceptability including a family planning special...

What is the current status of trial NCT03049592?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-07. Estimated completion is 2017-10.

What conditions does trial NCT03049592 study?

This clinical trial studies the following conditions: Diabetes, Contraception.

What interventions are being tested in trial NCT03049592?

The interventions under investigation include: HIBISCUS counseling (OTHER).

Who is sponsoring clinical trial NCT03049592?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03049592 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.